DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 90 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $74,183,000 | -38.5% | 2,183,143 | -33.8% | 0.82% | -33.3% |
| Q2 2021 | $120,714,000 | +95.0% | 3,297,301 | +138.8% | 1.22% | +110.9% |
| Q1 2021 | $61,920,000 | -3.6% | 1,380,900 | +22.7% | 0.58% | +3.0% |
| Q4 2020 | $64,244,000 | +11.2% | 1,125,700 | 0.0% | 0.56% | -22.6% |
| Q3 2020 | $57,748,000 | -14.1% | 1,125,700 | 0.0% | 0.73% | -23.3% |
| Q2 2020 | $67,227,000 | +41.1% | 1,125,700 | -2.8% | 0.95% | +18.1% |
| Q1 2020 | $47,658,000 | -49.4% | 1,157,600 | -23.5% | 0.80% | -40.4% |
| Q4 2019 | $94,242,000 | +12.8% | 1,514,171 | -38.5% | 1.34% | -15.1% |
| Q3 2019 | $83,512,000 | +2.4% | 2,460,571 | -32.0% | 1.58% | +25.4% |
| Q2 2019 | $81,590,000 | -2.8% | 3,618,171 | 0.0% | 1.26% | -2.8% |
| Q1 2019 | $83,978,000 | +63.8% | 3,618,171 | +48.2% | 1.30% | +37.1% |
| Q4 2018 | $51,262,000 | -32.2% | 2,442,200 | +25.0% | 0.95% | +4.1% |
| Q3 2018 | $75,640,000 | -4.2% | 1,953,500 | -2.6% | 0.91% | -3.2% |
| Q2 2018 | $78,924,000 | +156.9% | 2,005,700 | +30.8% | 0.94% | +147.0% |
| Q1 2018 | $30,719,000 | +15.2% | 1,532,900 | +30.3% | 0.38% | +13.1% |
| Q4 2017 | $26,662,000 | +256.1% | 1,176,070 | +198.3% | 0.34% | +368.1% |
| Q3 2017 | $7,487,000 | – | 394,270 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |